Adenovirus is a common virus that causes infectious diseases of the respiratory tract, eyes and gastrointestinal tract in humans and animals. Researchers at Umeå University study molecular mechanisms of infection in order to understand how adenovirus causes disease.
The researchers in Umeå, together with research groups from Germany, the UK and Hungary, have now discovered a new type of mechanism used by a rare adenovirus type to attack cells.
Human Adenovirus type 52 (HAdV-52) is one of the few adenoviruses that has two different types of fiber proteins on its surface, which are ‘used’ by the virus for the attachment to target cells. In collaboration with researchers in the Glycosciences Laboratory at Imperial College in London, who are world leading in the research field of glycobiology, the scientists have shown that the shorter fiber binds to an unusual type of carbohydrate-based receptor, polysialic acid (a long chain of repeated sialic acids). Annasara Lenman working with Niklas Arnberg has subsequently corroborated that HAdV-52 binds to polysialic acid on target cells, and that this leads to infection. In collaboration with experts in structural biology at the University of Tübingen, the interaction between the short fiber and polysialic acid has been mapped at the atomic level.
“We knew earlier that the short fiber binds to sialic acid, but not how the underlying carbohydrate chain was constructed,” explains Annasara Lenman postdoc at the Department of Clinical Microbiology and The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umeå University.
As polysialic acid is overexpressed on cancer cells in the brain and lungs, our findings could open new possibilities to use HAdV-52 for treatment for the corresponding types of cancer.
For a long time, adenovirus and other viruses have been considered suitable weapons for the treatment of different types of cancer. Viruses can kill cancer cells themselves, but in recent years it has also been understood that a virus infection in a tumor can activate the immune system against the cancer cells. You can also “arm” viruses with different genes that can for example counteract the development of resistance against different drugs. A major challenge has been to target viruses specifically against the cancer cells.
“Most adenoviruses tested so far have only one type of cell-binding fiber. HAdV-52 has two different fibers, one of which has a natural predilection for cancerous cells that express polysialic acid. This opens up a more effective harnessing of viruses against the right kind of cells”, Annasara Lenman explains.
The results can also be of importance in other research areas:
“Perhaps the most important function of polysialic acid is its contribution to the brain’s development. However, one has not known much about how polysialic acid interacts with its environment. Our research makes it pertinent to investigate whether polysialic acidplays a part in brain development by interacting with specific cellular molecules.” says Annasara Lenman.
The Latest on: Adenovirus
via Google News
The Latest on: Adenovirus
- Blood Clots Post Covid-19 Vaccination Can Be Due to Wrong Injection Technique, Says Studyon July 2, 2021 at 11:05 pm
Dr. Jayadevan had however ad warned early in April regarding the possibility of faulty injection technique being responsible for some of the rare clotting seen after Covid vaccination.
- J&J Vaccine Recipients Seek mRNA Booster Without CDC’s Blessingon July 2, 2021 at 4:00 am
Some people who received the Johnson & Johnson Covid-19 shot in the U.S. are seeking out added doses of a messenger-RNA vaccine, fearing their initial inoculation won’t protect them from the virus.
- Covid 19: Thrombosis After mRNA Vax Rare, But Possibleon June 30, 2021 at 5:18 am
Although thrombosis with thrombocytopenia has been reported after vaccination with adenovirus vector vaccines for Covid-19, researchers have now reported the first case of vaccine-induced thrombosis ...
- More evidence that mixing COVID-19 vaccines may help elicit a robust immune responseon June 29, 2021 at 12:03 pm
Using adenovirus-based vaccines in the heterologous vaccination strategy may be important for inducing and continuing T cell response, which may provide cross-protection in the face of emerging ...
- Why You Might Want a Booster Shot if You Got the J&J Vaccineon June 25, 2021 at 6:40 pm
Earlier this week, Angela Rasmussen, a virologist at the University of Saskatchewan, got a booster shot of the coronavirus vaccine. Previously, she’d received a dose of the single-shot vaccine ...
- Janssen Vaccine: What We Know and What We Don'ton June 23, 2021 at 8:41 am
The difference is in how each vaccine achieves that goal. The Johnson & Johnson vaccine (Ad26.COV2.S.) is based on a human adenovirus, a harmless virus that is used as a vehicle and that carries ...
via Bing News